OmniAb (OABI) Total Current Liabilities (2021 - 2026)
OmniAb (OABI) posted quarterly Total Current Liabilities of $13.6 million for Q1 2026, up 18.93% year-over-year from $11.4 million in Q1 2025, and down 16.54% quarter-over-quarter from $16.3 million in Q4 2025.
OmniAb (OABI) Total Current Liabilities (2021 - 2026) Analysis & Trends
OmniAb (OABI) has reported Total Current Liabilities for 6 consecutive years, with $13.6 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Total Current Liabilities rose 18.93% year-over-year to $13.6 million; the TTM figure through Mar 2026 stood at $13.6 million (up 18.93% YoY), while the FY2025 annual figure was $16.3 million, up 7.73% from the prior year.
- Total Current Liabilities slipped to $13.6 million in Q1 2026 per OABI's latest filing, from $16.3 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $26.0 million in Q4 2022 and bottomed at $5.5 million in Q1 2022.
- Historically, Total Current Liabilities has averaged $15.9 million across 5 years, with a median of $14.4 million in 2024.
- Annual changes were most pronounced in 2022 — Total Current Liabilities jumped 10598.67% — and 2024, when it tumbled 42.53%.
- OmniAb's Total Current Liabilities stood at $26.0 million in 2022, then fell by 11.17% to $23.1 million in 2023, then slumped by 34.73% to $15.1 million in 2024, then gained by 7.73% to $16.3 million in 2025, then declined by 16.54% to $13.6 million in 2026.
- Business Quant data shows OABI's Total Current Liabilities at $13.6 million in Q1 2026, $16.3 million in Q4 2025, and $13.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 3.94 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 5.53 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.58 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 354.06 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 2.12 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 4.22 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 630.93 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.51 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 438.74 Mn |
| 10 | OmniAb | 491.42 Mn | 439.42 Mn | 12.81 Mn | 13.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 13.76 Mn |
| Mar 31, 2026 | 13.57 Mn |
| Dec 31, 2025 | 16.25 Mn |
| Sep 30, 2025 | 13.28 Mn |
| Jun 30, 2025 | 12.64 Mn |
| Mar 31, 2025 | 11.41 Mn |
| Dec 31, 2024 | 15.09 Mn |
| Sep 30, 2024 | 14.40 Mn |
| Jun 30, 2024 | 14.15 Mn |
| Mar 31, 2024 | 17.52 Mn |
| Dec 31, 2023 | 23.12 Mn |
| Sep 30, 2023 | 25.06 Mn |
| Jun 30, 2023 | 24.24 Mn |
| Mar 31, 2023 | 21.68 Mn |
| Dec 31, 2022 | 26.02 Mn |
| Sep 30, 2022 | 10.27 Mn |
| Jun 30, 2022 | 6.98 Mn |
| Mar 31, 2022 | 5.46 Mn |
| Dec 31, 2021 | 20.58 Mn |
| Sep 30, 2021 | 95,969.00 |